Indication

Atelvia^® (risedronate sodium) is a prescription medication used to treat osteoporosis in women after menopause.

 

Important Safety Information for Atelvia^® (risedronate sodium) delayed-release tablets

You should not take Atelvia^® if you are on Actonel^® (risedronate sodium), have problems of the esophagus which delay emptying into the stomach, have low blood calcium (hypocalcemia), cannot stand or sit upright for at least 30 minutes, or are allergic to any of the ingredients.

Stop taking Atelvia^® and tell your doctor right away if you have trouble or pain when you swallow, chest pain, or new or worsening heartburn, as these may be signs of serious upper digestive problems. Take Atelvia^® right after breakfast and follow dosing instructions carefully to lower the chance of these events occurring. Regularly talk to your doctor about how long taking Atelvia^® for the treatment of osteoporosis is right for you.

Side effects may include diarrhea, flu-like symptoms, stomach pain, upset stomach, or back, muscle, bone or joint pain, sometimes severe. Contact your doctor for medical advice about side effects, or if you have questions about Atelvia^®. Promptly tell your doctor if you develop dental problems, as serious jawbone problems have been reported rarely. Inform your doctor of any new or unusual pain in your hip, groin, or thigh as unusual thigh bone fractures have been reported rarely.

Please read the Medication Guide for Atelvia^®, found at the end of the Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Atelvia^® is a registered trademark of Warner Chilcott Company, LLC.
Actonel^® is a registered trademark of Warner Chilcott Company, LLC.